JDC TECHNICAL EVALUATION REPORT

Subject: Carrick Group / BMS International & Seamair Insurance DAC

Reference: UID 6082

Market Authority: London & International Markets

Case Ref: ACQ-CARR-PHARM

Related Case Files: N/A

Date: 15.06.2026

Status: Completed

Case Summary (Tier 4):

Carrick Group has executed a dual sweep, simultaneously acquiring both BMS International Insurance DAC and Seamair Insurance DAC. Taking on historical pharmaceutical liabilities requires forensic-level underwriting. Carrick is deliberately building a bespoke containment unit for this exact kind of complex, high-stakes tail risk.

Case Detail (Tier 5):

A strategic consolidation of specialist insurance vehicles operating within the pharmaceutical liability ecosystem.

Pharmaceutical risks often generate exceptionally long reporting tails, particularly where product liability and latent injury allegations are involved. Managing such exposures requires both patience and capital discipline, making them natural candidates for specialist consolidators.

Carrick’s acquisition of the DAC structures represents more than a simple ownership change. It concentrates expertise, governance and capital oversight within a dedicated platform capable of managing complex liabilities through their full lifecycle.

The transaction reflects a broader trend within the legacy market whereby niche liability classes are increasingly migrating away from traditional owners and into specialist run-off environments.

Rather than remaining fragmented, the liabilities are brought under a single strategic framework designed to maximise certainty and operational efficiency.

Additional Comment:
Illustrates the continuing expansion of legacy market activity beyond traditional asbestos-focused transactions.